Literature DB >> 22544691

A study on the stability and enzymatic activity of yeast alcohol dehydrogenase in presence of the self-assembling block copolymer Poloxamer 407.

Stefania Pucciarelli1, Giulia Bonacucina, Franco Bernabucci, Marco Cespi, Giovanna Mencarelli, Giusi Serena De Fronzo, Paolo Natalini, Giovanni Filippo Palmieri.   

Abstract

Yeast alcohol dehydrogenase (ADH) is an enzyme widely studied for biotechnological applications due to its involvement in fermentation industry, and various attempts to improve its catalytic properties and its thermal stability have been carried out. In this paper, the influence of a block copolymer (Poloxamer 407) on ADH enzymatic activity and thermal behaviour has been studied in order to get new insights about the use of poloxamers in formulation of sustained release systems for therapeutic proteins. Poloxamer 407 has the ability to form micelles and gel due to its self-assembling and thermoresponsive properties. The effect of the copolymer towards thermal stress and pH changes, which often reduce enzymes activity it has been investigated by means of enzymatic assays and differential scanning calorimetry. Results showed that at pH 9.1 and 7.3, the Poloxamer in the form of unimeric, micellar and gel state is able to effectively preserve the enzyme from thermoinactivation. In addition by calorimetric data Poloxamer 407 has showed an effect in preserving ADH from aggregation at pH 7.3. In conclusion, Poloxamer 407 seems to be very effective in protecting ADH from stress related events, like alkaline inactivation and aggregation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544691     DOI: 10.1007/s12010-012-9692-x

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  1 in total

1.  Could albumin affect the self-assembling properties of a block co-polymer system and drug release? An in-vitro study.

Authors:  Diego R Perinelli; Giulia Bonacucina; Stefania Pucciarelli; Marco Cespi; Luca Casettari; Valeria Polzonetti; Francesco Martino Carpi; Giovanni F Palmieri
Journal:  Pharm Res       Date:  2014-09-19       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.